Phase I Study of the BBP-398 in Patients With Advance Solid Tumors
NCT05621525
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
7
Enrollment
INDUSTRY
Sponsor class
Stopped
Business reason
Conditions
Advanced Solid Tumor
Advanced or Metastatic Non-small Cell Lung Cancer
Interventions
DRUG:
BBP-398
Sponsor
LianBio LLC